The activation of IL-17 cytokine was regarded as one of the critical process contributing to the dysfunction of keratinocytes and systemic inflammation (14), and the concentration of IL-17 was found to be high in patients with HS (34). The gene discussed is IL17A; the disease is histiocytic sarcoma.